Abstract:Background. Mounting evidence suggests that most tumors consist of a heterogeneous population of cells with a subset population that has the exclusive tumorigenic ability. They are called cancer stem cells (CSCs). CSCs can self-renew to generate additional CSCs and also differentiate to generate phenotypically diverse cancer cells with limited proliferative potential. They have been identified in a variety of tumors. In this study, we identify the marker of CSCs in the established human laryngeal tumor Hep-2 cell line in vivo. Our in vitro experiment shown as CD133, a 5-transmembrane glycoprotein expressed in Hep-2 cell line. CD133 was supposed as a candidate of CSC in laryngeal carcinoma. In this study, the expression of CD133 was detected in a Hep-2 cell line. Applying the magnetic cell sorting (MACS) technology, we reported the results of purifying CD133 positive cells from a Hep-2 cell line. Three-type cells' tumor-forming ability was examined in vivo to identify the marker of CSCs in Hep-2 cell line.Methods. CD133 was selected as a putative marker of CSC in laryngeal carcinoma, Hep-2 cell lines. Flow cytometry was used to detect the expression of CD133 in the Hep-2 cell line. immunomagnetic beads were applied to purify CD133-positive cells. CD133(+), CD133(-) tumor cells, and unsorted Hep-2 cells were injected into severe combined immune deficiency (SCID) mice individually to observe tumor-forming ability.Results. Only a small proportion (3.15% +/- 0.83%) of cells in the Hep-2 cell line express the CD133 marker. In comparison with CD133(-) tumor cells and unsorted cells, CD133(+) cells possess a marked capacity for tumor formation in vivo (p <.05).Conclusion. CD133 is 1 of the markers for CSCs in human laryngeal tumors of the Hep-2 cell line. Work on the characterization of these cells provides a powerful tool to investigate the tumorigenic process in the larynx and to develop therapies targeting the CSC. (C) 2008 Wiley Periodicals, Inc. Head Neck 31: 94-101,2009

The Identification and Characterization of Cancer Stem Cells from Small Cell Lung Cancer Cell Line H446

Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells.

Cd133 Is A Temporary Marker Of Cancer Stem Cells In Small Cell Lung Cancer, But Not In Non-Small Cell Lung Cancer

Identification and Characterization of CD133(pos) Subpopulation Cells from a Human Laryngeal Cancer Cell Line.

Quantitative Analyses of CD133 Expression Facilitate Researches on Tumor Stem Cells.

Most C6 Cells Are Cancer Stem Cells: Evidence from Clonal and Population Analyses.

In Vivo Investigation of Cd133 As A Putative Marker of Cancer Stem Cells in Hep-2 Cell Line

[Isolation and in Vivo Tumorigenicity Assay of CD133+ Side Population Cells from Laryngeal Cancer Cell Line].

Cd133, One of the Markers of Cancer Stem Cells in Hep-2 Cell Line

[Isolation and in Vitro Characterization of CD133(+) Side Population Cells from Laryngeal Cancer Cell Line].

Identification and Characterization of Tumorigenic Liver Cancer Stem Cells by Cd133 and Cd24

Isolation and Characterization of Cancer Stem-Like Cells from MHCC97H Cell Lines

Biologic characteristics of the side population of human small cell lung cancer cell line H446.

Isolation and identification of CD133~+ colon cancer stem cells from colon cancer cell line HCT116

Identification of Cancer Stem-Like Cells in the C6 Glioma Cell Line and the Limitation of Current Identification Methods

A Validation Study of CD133 as a Reliable Marker for Identification of Colorectal Cancer Stem-Like Cells

Comparison of biological characteristics of CD133 + and CD133 - subpopulation of hepatocellular carcinoma cell line SMMC7721

Isolation and Identification of Cancer Stem-Like Cells from Murine Melanoma Cell Lines.

Cooperation of Side Population Cells with CD133 to Enrich Cancer Stem Cells in a Laryngeal Cancer Cell Line

Phenotypic analysis of common cancer stem cell markers and cell sorting in lung cancer cell line A549

Primary Study of Expression of CD133 in Human Non-Small Cell Lung Cacer and Cell Lines